Few of us today understand the significance of the work of two women biologists in 1959: Dr. Bernice Eddy, PhD, US Public Health Service, and Dr. Sarah Stewart, MD PhD, NIH.
Asked to discontinue testing of influenza after 2 decades at the Hygienic lab as she called it, Dr. Bernice Eddy, PhD was given in 1954 the task of testing the new Salk vaccine. Her results were not very encouraging for the first inoculated monkeys were paralyzed shortly after the inoculations. Nevertheless, “We had eighteen monkeys. We inoculated these eighteen monkeys with each vaccine that came in. And we started getting paralyzed monkeys.”
She reported to her superiors that the lots were Cutter’s, and sent pictures of the paralyzed monkeys along as well. “They were going to be injecting this thing into children.” pharmaceutical companies vigorously began marketing the vaccine to include the notorious Cutters Pharmaceuticals who did not successfully inactivate the vaccine by formalinizing it. Formalinizing a vaccine is the process of applying formaldehyde, a chemical embalming agent, to a virus to “kill or inactivate” the virus protein. Recipients of the Cutters Pharmaceutical vaccine were young healthy children who contracted polio after vaccination and became paralyzed.
Contracting disease from an innoculation is not a new occurrence in science, for James Fox in the book Laboratory Animal Medicine 2nd ed. James G. Fox, Lynn C. Anderson, Franklin M. Loew, Fred W. Quimby, American College of Laboratory Animal Medicine Series p. 566 paragraph 2. notes “
James Fox’s book is a peer reviewed microbiologists lab science manual and asserts that congenital defects occur in lab animals following vaccinations at a higher rate than a “wild virus/microbe” infection.
Dr. Eddy had concern for the immediately occurring adverse effects of the polio vaccine and kept tissue samples of the green monkey kidney virus in polio vaccine samples. By the late 1950s she and a peer female scientist and cultured it with the help of Dr. Sarah Stewart, MD PhD at the NIH.
Their work carefully documented and demonstrated the cultivation of cancer in many animals and their fear was that the continued innocculation of polio into humans would result in a human cancer epidemic.
In spite of Dr. Eddy’s presentation of evidence at the New York Cancer Society in 1960, millions of additional people were needlessly exposed to the cancer virus in polio vaccine. The count was at least 98 million Americans from 1955 to 1963 as Debbie Bookchin and Jim Schumacher reported in the Atlantic Online.
After retirement in 1973, Dr. Eddy took a consultant position with the 11th year of the US Special Cancer Virus Program sponsored by Rockefeller funding, with annual meetings at the Rockefeller Hershey Medical Center in Hershey, Pennsylvania. 7 of the annual reports of this $550 million program that spanned 16 years from 1962-1978 have been peer reviewed by doctors and biologists worldwide to include Donald Scott, MS and Bill Scott, MS of the Common Cause Medical Research Foundation, Sudbury, Ontario, Canada, the honorable Dr. Edgar Ngoma, MD, Lusaka, Angola, initiator of the April 2007 clinical trials at the Clinica Esperanca of Tetrasilver tetroxide in Lusaka, Angola, Dr. Jose Van Dunem, Health Minister of Angola in 2007, Dr. Alan Cantwell, MD, to name a few.
Carbone, Pass, and Procopio proposed SV40 as a possible co-carcinogen in human mesothelioma.
The Work of Drs. Bernice Eddy, PhD, and Dr. Sarah Stewart
This peer reviewed article will show Characteristics of the SE Polyoma Virus:
American Journal of Public Health and the Nations Health: November 1959, Vol. 49, No. 11: 1486–1492.
This peer reviewed article will show studies of mouse polyoma virus infection:
Tumor Induction by SE Polyoma Virus and the Inhibition of Tumors by Specific Neutralizing Antibodies
American Journal of Public Health and the Nations Health: November 1959, Vol. 49, No. 11: 1493–1496.